These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32552166)

  • 1. Novel drug targets for treatment of cryptosporidiosis.
    Wang B; Castellanos-Gonzalez A; White AC
    Expert Opin Ther Targets; 2020 Sep; 24(9):915-922. PubMed ID: 32552166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic screening techniques for
    Love MS; McNamara CW
    Expert Opin Drug Discov; 2021 Jan; 16(1):59-74. PubMed ID: 32892652
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of cryptosporidiosis: nitazoxanide yes, but we can do better.
    Caravedo MA; White AC
    Expert Rev Anti Infect Ther; 2023 Feb; 21(2):167-173. PubMed ID: 36533398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel treatment strategies and drugs in development for cryptosporidiosis.
    Chavez MA; White AC
    Expert Rev Anti Infect Ther; 2018 Aug; 16(8):655-661. PubMed ID: 30003818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis.
    Love MS; Beasley FC; Jumani RS; Wright TM; Chatterjee AK; Huston CD; Schultz PG; McNamara CW
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005373. PubMed ID: 28158186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current pharmacotherapy of cryptosporidiosis: an update of the state-of-the-art.
    Schneider A; Wendt S; Lübbert C; Trawinski H
    Expert Opin Pharmacother; 2021 Dec; 22(17):2337-2342. PubMed ID: 34281461
    [No Abstract]   [Full Text] [Related]  

  • 7. Cryptosporidiosis Drug Discovery: Opportunities and Challenges.
    Manjunatha UH; Chao AT; Leong FJ; Diagana TT
    ACS Infect Dis; 2016 Aug; 2(8):530-7. PubMed ID: 27626293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the safety, tolerability, pharmacokinetics and efficacy of clofazimine in cryptosporidiosis (CRYPTOFAZ): study protocol for a randomized controlled trial.
    Nachipo P; Hermann D; Quinnan G; Gordon MA; Van Voorhis WC; Iroh Tam PY
    Trials; 2018 Aug; 19(1):456. PubMed ID: 30139372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging treatment options for cryptosporidiosis.
    Love MS; Choy RKM
    Curr Opin Infect Dis; 2021 Oct; 34(5):455-462. PubMed ID: 34261904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Past, current, and potential treatments for cryptosporidiosis in humans and farm animals: A comprehensive review.
    Khan SM; Witola WH
    Front Cell Infect Microbiol; 2023; 13():1115522. PubMed ID: 36761902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and Pharmacodynamics of Clofazimine for Treatment of Cryptosporidiosis.
    Zhang CX; Love MS; McNamara CW; Chi V; Woods AK; Joseph S; Schaefer DA; Betzer DP; Riggs MW; Iroh Tam PY; Van Voorhis WC; Arnold SLM
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0156021. PubMed ID: 34748385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitazoxanide in the treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired immunodeficiency syndrome in tropical Africa.
    Doumbo O; Rossignol JF; Pichard E; Traore HA; Dembele TM; Diakite M; Traore F; Diallo DA
    Am J Trop Med Hyg; 1997 Jun; 56(6):637-9. PubMed ID: 9230795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium.
    Checkley W; White AC; Jaganath D; Arrowood MJ; Chalmers RM; Chen XM; Fayer R; Griffiths JK; Guerrant RL; Hedstrom L; Huston CD; Kotloff KL; Kang G; Mead JR; Miller M; Petri WA; Priest JW; Roos DS; Striepen B; Thompson RC; Ward HD; Van Voorhis WA; Xiao L; Zhu G; Houpt ER
    Lancet Infect Dis; 2015 Jan; 15(1):85-94. PubMed ID: 25278220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in therapeutic and vaccine targets for Cryptosporidium: Challenges and possible mitigation strategies.
    Rahman SU; Mi R; Zhou S; Gong H; Ullah M; Huang Y; Han X; Chen Z
    Acta Trop; 2022 Feb; 226():106273. PubMed ID: 34906550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptic parasite revealed improved prospects for treatment and control of human cryptosporidiosis through advanced technologies.
    Jex AR; Smith HV; Nolan MJ; Campbell BE; Young ND; Cantacessi C; Gasser RB
    Adv Parasitol; 2011; 77():141-73. PubMed ID: 22137584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in genetic manipulation of Cryptosporidium.
    Vinayak S
    Curr Opin Microbiol; 2020 Dec; 58():146-152. PubMed ID: 33161368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug treatment and novel drug target against Cryptosporidium.
    Gargala G
    Parasite; 2008 Sep; 15(3):275-81. PubMed ID: 18814694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial.
    Amadi B; Mwiya M; Musuku J; Watuka A; Sianongo S; Ayoub A; Kelly P
    Lancet; 2002 Nov; 360(9343):1375-80. PubMed ID: 12423984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment and prevention of cryptosporidiosis: what options are there for a country like Zambia?
    Kelly P
    Parasitology; 2011 Oct; 138(12):1488-91. PubMed ID: 21320387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calf Clinical Model of Cryptosporidiosis for Efficacy Evaluation of Therapeutics.
    Riggs MW; Schaefer DA
    Methods Mol Biol; 2020; 2052():253-282. PubMed ID: 31452167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.